Contrasting American Well (AMWL) and Its Peers

American Well (NYSE:AMWL) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it weigh in compared to its peers? We will compare American Well to related businesses based on the strength of its institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation.

Insider & Institutional Ownership

56.0% of American Well shares are owned by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares American Well and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
American Well	-27.03%	-24.32%	-17.91%
American Well Competitors	-750.30%	-29.45%	-15.32%

Risk and Volatility

American Well has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500. Comparatively, American Well’s peers have a beta of 1.11, meaning that their average stock price is 11% more volatile than the S&P 500.

Earnings & Valuation

This table compares American Well and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
American Well	$249.32 million	-$95.70 million	-3.42
American Well Competitors	$341.86 million	-$24.15 million	12.85

American Well’s peers have higher revenue and earnings than American Well. American Well is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of recent ratings for American Well and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1	5	1	0	2.00
American Well Competitors	455	1537	2754	89	2.51

American Well currently has a consensus target price of $12.30, suggesting a potential upside of 4.41%. As a group, “Healthcare Technology” companies have a potential upside of 44.60%. Given American Well’s peers stronger consensus rating and higher probable upside, analysts clearly believe American Well has less favorable growth aspects than its peers.

Summary

American Well peers beat American Well on 9 of the 13 factors compared.

American Well Company Profile

American Well Corporation, which operates as Amwell, provides digital healthcare technology and services. Its platform helps health systems, health plans and other healthcare organizations offer virtual care and connect patients with clinicians. Amwell’s offerings include telehealth visits and tools for behavioral health, chronic care, primary care and specialty services. Its technology is designed to support care across digital and in-person settings, with clinical services delivered by healthcare providers and partner organizations.